BLAST PHASE MYELOPROLIFERATIVE NEOPLASM
Clinical trials for BLAST PHASE MYELOPROLIFERATIVE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new BLAST PHASE MYELOPROLIFERATIVE NEOPLASM trials appear
Sign up with your email to follow new studies for BLAST PHASE MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to bridge blood cancer patients to Life-Saving transplant
Disease control Recruiting nowThis phase 2 trial is testing whether adding the drug pacritinib to standard treatments (azacitidine or decitabine) can help more people with advanced myeloproliferative neoplasms (MPN) get a stem cell transplant. The study will enroll 27 adults whose MPN has progressed to a more…
Matched conditions: BLAST PHASE MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
5,000 patients join Long-Term study to unlock mysteries of rare blood cancers
Knowledge-focused Recruiting nowThis study is a long-term observation of 5,000 adults with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect health records, insurance data, and patient surveys over at least five years to track symptoms, treatments, and how the disease …
Matched conditions: BLAST PHASE MYELOPROLIFERATIVE NEOPLASM
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:04 UTC